Nugumanova, Galina; Ponomarev, Eugene D; Askarova, Sholpan; Fasler-Kan, Elizaveta; Barteneva, Natasha S (2023). Freshwater Cyanobacterial Toxins, Cyanopeptides and Neurodegenerative Diseases. Toxins, 15(3) MDPI 10.3390/toxins15030233
|
Text
toxins-15-00233-v2.pdf - Published Version Available under License Creative Commons: Attribution (CC-BY). Download (2MB) | Preview |
Cyanobacteria produce a wide range of structurally diverse cyanotoxins and bioactive cyanopeptides in freshwater, marine, and terrestrial ecosystems. The health significance of these metabolites, which include genotoxic- and neurotoxic agents, is confirmed by continued associations between the occurrence of animal and human acute toxic events and, in the long term, by associations between cyanobacteria and neurodegenerative diseases. Major mechanisms related to the neurotoxicity of cyanobacteria compounds include (1) blocking of key proteins and channels; (2) inhibition of essential enzymes in mammalian cells such as protein phosphatases and phosphoprotein phosphatases as well as new molecular targets such as toll-like receptors 4 and 8. One of the widely discussed implicated mechanisms includes a misincorporation of cyanobacterial non-proteogenic amino acids. Recent research provides evidence that non-proteinogenic amino acid BMAA produced by cyanobacteria have multiple effects on translation process and bypasses the proof-reading ability of the aminoacyl-tRNA-synthetase. Aberrant proteins generated by non-canonical translation may be a factor in neuronal death and neurodegeneration. We hypothesize that the production of cyanopeptides and non-canonical amino acids is a more general mechanism, leading to mistranslation, affecting protein homeostasis, and targeting mitochondria in eukaryotic cells. It can be evolutionarily ancient and initially developed to control phytoplankton communities during algal blooms. Outcompeting gut symbiotic microorganisms may lead to dysbiosis, increased gut permeability, a shift in blood-brain-barrier functionality, and eventually, mitochondrial dysfunction in high-energy demanding neurons. A better understanding of the interaction between cyanopeptides metabolism and the nervous system will be crucial to target or to prevent neurodegenerative diseases.
Item Type: |
Journal Article (Review Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Gynaecology, Paediatrics and Endocrinology (DFKE) > Clinic of Paediatric Surgery |
UniBE Contributor: |
Fasler-Kan, Elizaveta |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
2072-6651 |
Publisher: |
MDPI |
Language: |
English |
Submitter: |
Pubmed Import |
Date Deposited: |
29 Mar 2023 09:59 |
Last Modified: |
30 Mar 2023 21:59 |
Publisher DOI: |
10.3390/toxins15030233 |
PubMed ID: |
36977124 |
Uncontrolled Keywords: |
Alzheimer’s disease BMAA Parkinson’s disease amyotrophic lateral sclerosis cyanopeptides cyanotoxins gut-brain axis harmful algal blooms microcystin mistranslation neurodegenerative disease non-proteogenic amino acids |
BORIS DOI: |
10.48350/180898 |
URI: |
https://boris.unibe.ch/id/eprint/180898 |